Castle Biosciences (CSTL) Preferred Stock Liabilities (2018 - 2019)
Castle Biosciences (CSTL) posted Preferred Stock Liabilities of $45.1 million for Q2 2019, little changed sequentially from $45.1 million in Q1 2019, and up 2905.19% YoY from $1.5 million in Q2 2018.
Castle Biosciences (CSTL) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends
Castle Biosciences (CSTL) has 2 years of Preferred Stock Liabilities data on file, last reported at $45.1 million in Q2 2019.
- Quarterly Preferred Stock Liabilities rose 2905.19% year-over-year to $45.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $45.1 million (up 2905.19% YoY) and the FY2018 annual result came in at $45.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $45.1 million in Q2 2019 per CSTL's latest filing, from $45.1 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $45.1 million in Q2 2019, with the low at $1.5 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 45.11 Mn |
| Mar 31, 2019 | 45.05 Mn |
| Dec 31, 2018 | 45.00 Mn |
| Sep 30, 2018 | 44.94 Mn |
| Jun 30, 2018 | 1.50 Mn |